Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

6.93
+0.10001.46%
Post-market: 6.90-0.0300-0.43%19:50 EDT
Volume:6.04M
Turnover:42.23M
Market Cap:2.43B
PE:-15.80
High:7.09
Open:6.98
Low:6.88
Close:6.83
52wk High:9.75
52wk Low:2.76
Shares:351.12M
Float Shares:264.00M
Volume Ratio:0.72
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4387
EPS(LYR):-0.6000
ROE:-47.81%
ROA:-12.36%
PB:9.58
PE(LYR):-11.55

Loading ...

Nuvation Bio Q1 net income turns positive on IBTROZI sales

Reuters
·
May 05

Nuvation Bio Q1 EPS $0.01, Inline, Sales $83.228M Beat $62.259M Estimate.

Benzinga Earnings
·
May 05

BRIEF-Nuvation Bio Q1 EPS USD 0.01

Reuters
·
May 05

Nuvation Bio Q1 Pretax Profit USD 5.397 Million

THOMSON REUTERS
·
May 05

Press Release: Nuvation Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 05

BRIEF-Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (Ibtrozi®) As Recommended Option

Reuters
·
Apr 27

Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (Ibtrozi®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers

THOMSON REUTERS
·
Apr 27

Earning Preview: Nuvation Bio, Inc. Q1 revenue is expected to increase by 14,240.76%, and institutional views are bullish

Earnings Agent
·
Apr 27

Nuvation Bio reports results from TRUST-I and TRUST-II trials for IBTROZI

TIPRANKS
·
Apr 22

Nuvation Bio publishes corporate presentation on IBTROZI launch, oncology pipeline updates

Reuters
·
Apr 22

Nuvation Bio says pooled TRUST data show 49.7-month IBTROZI response duration

Reuters
·
Apr 22

Nuvation Bio Chief Regulatory Officer Kerry Wentworth sells 36,750 shares for $184,279

Reuters
·
Apr 22

Nuvation Bio CMO Liu Dongfang disposes 50,000 common shares for $251,000

Reuters
·
Apr 22

Nuvation Bio publishes 2025 annual report to stockholders

Reuters
·
Apr 21

Nuvation Bio schedules first-quarter financial results call and webcast

Reuters
·
Apr 21

Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026

THOMSON REUTERS
·
Apr 21

A Look At Nuvation Bio’s Valuation As Ibtrozi Uptake And Q1 Earnings Expectations Gain Attention

Simply Wall St.
·
Apr 18

Nuvation Bio's Ibtrozi Gains Frontline Momentum Ahead of Key Q1 Print, Wedbush Says

MT Newswires Live
·
Apr 16

Nuvation Bio Price Target Maintained With a $11.00/Share by Wedbush

Dow Jones
·
Apr 16

Nuvation Bio (NUVB) Gets a Buy from Wedbush

TIPRANKS
·
Apr 16